Browse hierarchy: [Gastroenterology, Urology (GU)](/submissions/GU) → [Subpart B — Diagnostic Devices](/submissions/GU/subpart-b%E2%80%94diagnostic-devices) → [21 CFR 876.1390](/submissions/GU/subpart-b%E2%80%94diagnostic-devices/876.1390) → QUD — Blood Detection Capsule

# QUD · Blood Detection Capsule

_Gastroenterology, Urology · 21 CFR 876.1390 · Class 2_

**Canonical URL:** https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QUD

## Overview

- **Product Code:** QUD
- **Device Name:** Blood Detection Capsule
- **Regulation:** [21 CFR 876.1390](/submissions/GU/subpart-b%E2%80%94diagnostic-devices/876.1390)
- **Device Class:** 2
- **Review Panel:** [Gastroenterology, Urology](/submissions/GU)

## Identification

An ingestible gastrointestinal blood detection capsule is a prescription device that uses spectrophotometry (light absorption technology) to detect the presence or absence of blood in the gastrointestinal tract. The Pill Sense System consists of a reusable receiver and a single-use ingestible capsule, intended to be used for the detection of blood in the upper gastrointestinal tract in hemodynamically stable adults suspected of having upper gastrointestinal bleeding (UGIB).

## Classification Rationale

Class II (special controls). The device is granted under De Novo classification (21 CFR 876.1390) as the probable benefits outweigh the probable risks, and the risks can be mitigated by the use of general controls and the identified special controls.

## Special Controls

In combination with the general controls of the FD&C Act. the ingestible gastrointestinal blood detection capsule is subject to the following special controls:

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [DEN220065](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QUD/DEN220065.md) | Pill Sense System | Enterasense , Ltd. | Feb 24, 2023 | DENG |

## Top Applicants

- Enterasense , Ltd. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QUD](https://fda.innolitics.com/submissions/GU/subpart-b%E2%80%94diagnostic-devices/QUD)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com